These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 2943647)

  • 1. [Male transsexuals. Hormone studies in endocrine therapy].
    Krause W; Jarrar K
    Fortschr Med; 1986 Jun; 104(23-24):471-3. PubMed ID: 2943647
    [No Abstract]   [Full Text] [Related]  

  • 2. A long-term follow-up study of mortality in transsexuals receiving treatment with cross-sex hormones.
    Asscheman H; Giltay EJ; Megens JA; de Ronde WP; van Trotsenburg MA; Gooren LJ
    Eur J Endocrinol; 2011 Apr; 164(4):635-42. PubMed ID: 21266549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hormone treatment of the adult transsexual patient.
    Gooren L
    Horm Res; 2005; 64 Suppl 2():31-6. PubMed ID: 16286768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Morbidity in transsexual patients with cross-gender hormone self-treatment].
    Becerra Fernández A; de Luis Román DA; Piédrola Maroto G
    Med Clin (Barc); 1999 Oct; 113(13):484-7. PubMed ID: 10604171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of a cyproterone-containing oral contraceptive on hormonal levels in polycystic ovarian disease.
    Calaf-Alsina J; Rodriguez-Espinosa J; Cabero-Roura A; Lenti-Paoli O; Mora-Brugues J; Esteban-Altirriba J
    Obstet Gynecol; 1987 Feb; 69(2):255-8. PubMed ID: 2949170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Venous thrombosis and changes of hemostatic variables during cross-sex hormone treatment in transsexual people.
    Toorians AW; Thomassen MC; Zweegman S; Magdeleyns EJ; Tans G; Gooren LJ; Rosing J
    J Clin Endocrinol Metab; 2003 Dec; 88(12):5723-9. PubMed ID: 14671159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Presentation of a meningioma in a transwoman after nine years of cyproterone acetate and estradiol intake: case report and literature review.
    Mancini I; Rotilio A; Coati I; Seracchioli R; Martelli V; Meriggiola MC
    Gynecol Endocrinol; 2018 Jun; 34(6):456-459. PubMed ID: 29105524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The sex difference of plasma homovanillic acid is unaffected by cross-sex hormone administration in transsexual subjects.
    Giltay EJ; Kho KH; Blansjaar BA; Verbeek MM; Geurtz PB; Geleijnse JM; Gooren LJ
    J Endocrinol; 2005 Oct; 187(1):109-16. PubMed ID: 16214946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of cross-gender hormonal treatment on bone metabolism in male-to-female transsexuals.
    Lips P; Asscheman H; Uitewaal P; Netelenbos JC; Gooren L
    J Bone Miner Res; 1989 Oct; 4(5):657-62. PubMed ID: 2530804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Handedness, functional cerebral hemispheric lateralization, and cognition in male-to-female transsexuals receiving cross-sex hormone treatment.
    Wisniewski AB; Prendeville MT; Dobs AS
    Arch Sex Behav; 2005 Apr; 34(2):167-72. PubMed ID: 15803250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential effects of cross-sex hormonal treatment on plasma asymmetric dimethylarginine (ADMA) in healthy male-to-female and female-to-male transsexuals.
    Bunck MC; Giltay EJ; Diamant M; Gooren LJ; Teerlink T
    Atherosclerosis; 2009 Sep; 206(1):245-50. PubMed ID: 19324362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of sex steroids on the neurotransmitter-specific aromatic amino acids phenylalanine, tyrosine, and tryptophan in transsexual subjects.
    Giltay EJ; Bunck MC; Gooren LJ; Zitman FG; Diamant M; Teerlink T
    Neuroendocrinology; 2008; 88(2):103-10. PubMed ID: 18511863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term treatment of transsexuals with cross-sex hormones: extensive personal experience.
    Gooren LJ; Giltay EJ; Bunck MC
    J Clin Endocrinol Metab; 2008 Jan; 93(1):19-25. PubMed ID: 17986639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of endometrial hyperplasia with cyproterone acetate histological and hormonal aspects.
    Jasonni VM; Franceschetti F; Ciotti P; Bulletti C; Vignudelli A; Marabini A; Naldi S; Flamigni C
    Acta Obstet Gynecol Scand; 1986; 65(7):685-7. PubMed ID: 2949483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prolactin levels and pituitary enlargement in hormone-treated male-to-female transsexuals.
    Asscheman H; Gooren LJ; Assies J; Smits JP; de Slegte R
    Clin Endocrinol (Oxf); 1988 Jun; 28(6):583-8. PubMed ID: 2978262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of sex steroid hormones on regional fat depots as assessed by magnetic resonance imaging in transsexuals.
    Elbers JM; Asscheman H; Seidell JC; Gooren LJ
    Am J Physiol; 1999 Feb; 276(2):E317-25. PubMed ID: 9950792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mortality and morbidity in transsexual patients with cross-gender hormone treatment.
    Asscheman H; Gooren LJ; Eklund PL
    Metabolism; 1989 Sep; 38(9):869-73. PubMed ID: 2528051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A short clinical trial of cyproterone acetate in the treatment of idiopathic hirsutism].
    Paggi A; Leri O; Parrettini S; Di Meo G; Corsi V
    Clin Ter; 1981 Feb; 96(4):443-53. PubMed ID: 6452246
    [No Abstract]   [Full Text] [Related]  

  • 19. Cross-sex hormone administration changes pain in transsexual women and men.
    Aloisi AM; Bachiocco V; Costantino A; Stefani R; Ceccarelli I; Bertaccini A; Meriggiola MC
    Pain; 2007 Nov; 132 Suppl 1():S60-S67. PubMed ID: 17379410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endocrine treatment of male-to-female transsexuals using gonadotropin-releasing hormone agonist.
    Dittrich R; Binder H; Cupisti S; Hoffmann I; Beckmann MW; Mueller A
    Exp Clin Endocrinol Diabetes; 2005 Dec; 113(10):586-92. PubMed ID: 16320157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.